FHL1 - four and a half LIM domains 1 Gene
Also Known as KYOT; SLIM; FCMSU; FHL-1; FHL1A; FHL1B; FLH1A; SLIM1; XMPMA; RBMX1A; RBMX1B; SLIM-1; SLIMMER
Species: Homo sapiens
About FHL1
This gene has 36 transcripts (splice variants), 214 orthologues, 20 paralogues and is associated with 12 phenotypes. Broad expression in heart (RPKM 286.6), fat (RPKM 281.6) and 18 other tissues.
Summary
This gene encodes a member of the four-and-a-half-LIM-only protein family. Family members contain two highly conserved, tandemly arranged, zinc finger domains with four highly conserved cysteines binding a zinc atom in each zinc finger. Expression of these family members occurs in a cell- and tissue-specific mode and these proteins are involved in many cellular processes. Mutations in this gene have been found in patients with Emery-Dreifuss muscular dystrophy. Multiple alternately spliced transcript variants which encode different protein isoforms have been described.[provided by RefSeq, Nov 2009]
FHL1 Products (15)
| mRNA | Protein | Name |
|---|---|---|
| NM_001159699.2 | NP_001153171.1 | four and a half LIM domains protein 1 isoform 5 |
| NM_001159700.2 | NP_001153172.1 | four and a half LIM domains protein 1 isoform 2 |
| NM_001159701.2 | NP_001153173.1 | four and a half LIM domains protein 1 isoform 3 precursor |
| NM_001159702.3 | NP_001153174.1 | four and a half LIM domains protein 1 isoform 1 |
| NM_001159703.2 | NP_001153175.1 | four and a half LIM domains protein 1 isoform 4 |
| NM_001159704.1 | NP_001153176.1 | four and a half LIM domains protein 1 isoform 2 |
| NM_001167819.1 | NP_001161291.1 | four and a half LIM domains protein 1 isoform 2 |
| NM_001330659.2 | NP_001317588.1 | four and a half LIM domains protein 1 isoform 6 |
| NM_001369326.1 | NP_001356255.1 | four and a half LIM domains protein 1 isoform 1 |
| NM_001369327.2 | NP_001356256.1 | four and a half LIM domains protein 1 isoform 1 |
| NM_001369328.1 | NP_001356257.1 | four and a half LIM domains protein 1 isoform 1 |
| NM_001369329.1 | NP_001356258.1 | four and a half LIM domains protein 1 isoform 2 |
| NM_001369330.1 | NP_001356259.1 | four and a half LIM domains protein 1 isoform 2 |
| NM_001369331.1 | NP_001356260.1 | four and a half LIM domains protein 1 isoform 2 |
| NM_001449.5 | NP_001440.2 | four and a half LIM domains protein 1 isoform 2 |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
18482256 | GOA |
| enables transmembrane transporter binding |
IPI
IPI: Inferred from physical interaction
|
18281375 | GOA |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| involved in negative regulation of G1/S transition of mitotic cell cycle |
IDA
IDA: Inferred from direct assay
|
21702045 | GOA |
| involved in negative regulation of G2/M transition of mitotic cell cycle |
IDA
IDA: Inferred from direct assay
|
21702045 | GOA |
| involved in negative regulation of cell growth |
IDA
IDA: Inferred from direct assay
|
21702045 | GOA |
| involved in positive regulation of potassium ion transport |
IDA
IDA: Inferred from direct assay
|
18281375 | GOA |
| involved in regulation of membrane depolarization |
IDA
IDA: Inferred from direct assay
|
18281375 | GOA |
| involved in regulation of potassium ion transmembrane transporter activity |
IDA
IDA: Inferred from direct assay
|
18281375 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| located in cytoplasm |
IDA
IDA: Inferred from direct assay
|
21702045 | GOA |
| located in nucleus |
IDA
IDA: Inferred from direct assay
|
21702045 | GOA |
| located in plasma membrane |
IDA
IDA: Inferred from direct assay
|
18281375 | GOA |
FHL1 Protein Structure
LIM: LIM domain (40 - 94)
LIM: LIM domain (101 - 158)
LIM: LIM domain (162 - 214)
- 0
- 100
- 200
- 300
- 323 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
four and a half LIM domains protein 1 |
|
FHL1 Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | References |
|---|---|---|---|---|---|---|---|
|
Intra
|
FHL1 | Q13642 | NRIP1 | Homo sapiens | P48552 | 19401155 | |
|
Intra
|
FHL1 | Q13642 | NRIP1 | Homo sapiens | P48552 | 19401155 | |
|
Intra
|
FHL1 | Q13642 | NRIP1 | Homo sapiens | P48552 | 19401155 |
FHL1 Antibodies
| Cat. No. | Product Name | Application | Reactivity |
|---|---|---|---|
| HY-P81923 | FHL1 Antibody (YA1668) | WB, IHC-P, IP | Human, Mouse, Rat |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Myopathy, X-Linked, With Postural Muscle Atrophy |
|
|
| Scapuloperoneal Myopathy, X-Linked Dominant |
|
|
| Reducing Body Myopathy, X-Linked 1a, Severe, With Infantile Or Early Childhood Onset |
|
|
| Reducing Body Myopathy, X-Linked 1b, With Late Childhood Or Adult Onset |
|
|
| Uruguay Faciocardiomusculoskeletal Syndrome |
|
|
| Reducing Body Myopathy |
|
|
| X-Linked Emery-Dreifuss Muscular Dystrophy |
|
|
| Scapuloperoneal Myopathy |
|
|
| Hemophagocytic Lymphohistiocytosis, Familial, 1 |
|
|
| Emery-Dreifuss Muscular Dystrophy |
|
|
| Muscle Hypertrophy |
|
|
| Chikungunya |
|
|
| Progressive Muscular Dystrophy |
|
|
| Foot Drop |
|
|
| Muscular Dystrophy |
|
|
| Cardiomyopathy, Familial Hypertrophic, 1 |
|
|
| Myofibrillar Myopathy |
|
|
| Myopathy |
|
|
| Rigid Spine Muscular Dystrophy 1 |
|
|
| Clubfoot |
|
|
| Emery-Dreifuss Muscular Dystrophy 5, Autosomal Dominant |
|
|
| Emery-Dreifuss Muscular Dystrophy 4, Autosomal Dominant |
|
|
| Respiratory Failure |
|
|
| Muscular Dystrophy, Congenital, Lmna-Related |
|
|
| Scoliosis |
|
|
| Hypertrophic Cardiomyopathy |
|
|
| Dilated Cardiomyopathy |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Canis familiaris | FHL1 | VGNC | VGNC:40871 |
| Mus musculus | FHL1 | MGD | MGI:1298387 |
| Rattus norvegicus | FHL1 | RGD | RGD:2615 |
| Macaca mulatta | FHL1 | VGNC | VGNC:72660 |
| Felis catus | FHL1 | VGNC | VGNC:62264 |
| Bos taurus | FHL1 | VGNC | VGNC:28999 |
| Others | FHL1 | NCBI |